PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go:
Extended
investment:
£10,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
CapitalRise is an online property lending platform offering market-leading returns of 7-12% per annum from secured lending to prime real estate. Till date, the company has lent £71.9 million against assets worth over £410 million, repaid £28 million of capital and return to customers, and saw a 354% increase in revenues in 2019. CapitalRise is ranked #1 in both 1-year and 3-year net returns as verified by leading loan analytics firm, Brismo. The company has won awards including, the British Bank Awards 2020 - Best Alternative Finance Provider. It has also received press coverage from publications such as The Times, Forbes and Daily Express. It will use the investment to take advantage of the UK government's Future Fund given the positive feedback from its investors, improve its technology platforms, further its marketing and lending initiatives, and satisfy customer expectations.
days to go:
Expired
investment:
£2,214,280
DeadHappy is a digital-first life insurance provider that aims to disrupt the £3.7 billion life insurance market. The company claims that traditional life insurance is complex, expensive, and inflexible. DeadHappy argues that it can offer customers a cheap, flexible and enjoyable alternative. It has developed a unique pay-as-you-go life insurance product with a rolling 10 year guarantee of cover. A simple sign-up process allows customers to answer only 4 medical questions & obtain cover in under 5 minutes, on-line, via their mobile phone. The company's proprietary Deathwish Platform enables customers to personalise their life insurance by creating ‘Deathwishes’. In 2020, DeadHappy reached 120,000+ total deathwishes and has sold 7,800+ total life insurance policies. The company will use 35% of the investment for company growth, 30% for technology development, 20% for product development, and 15% to build partnerships.
days to go:
Expired
investment:
£2,703,820
WebStart Bristol provide startup web service businesses with the workspace and technical support to really help them succeed. To date, WebStart Bristol have helped 24 startups. The use of the proceeds will go towards the continuing support of the growing web start companies.
days to go:
Expired
investment:
£50,327
Helping SME home builders acquire finance for their projects in the UK. Rubicon Capital has assisted more than 40 project developers in receiving investments for their builds, which has exceeded £75m. In their second year, the company generated £500k in profits and has successfully paid dividends every year since launching in 2015. Two main sources of revenue are upfront fees for connecting borrowers with lenders and administration fees in the form of long-term consultancy and performance assistance.
Money raised from this crowdfunding round will be used to expand the Rubicon Capital team and grow their business to attract more home builders requiring financial assistance, in addition to increasing the number of sources offering finance.
days to go:
Expired
investment:
£128,510
